Focus: ExThera Medical is a public biotechnology company specializing in blood filtration and extracorporeal therapies across infectious diseases, cardiovascular, oncology, ophthalmology, and nephrology. The company operates at modest scale with only 2 active job openings and a focused product portfolio.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
ExThera is a niche, stable public biotech with a narrow hiring aperture—suitable only for candidates seeking specialized blood filtration/extracorporeal expertise in a mature, low-growth environment.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ExThera Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ExThera Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
EP2 receptor agonist approved for glaucoma management; represents the company's sole marketed product with 15+ years of patent runway.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo